<DOC>
	<DOC>NCT01103544</DOC>
	<brief_summary>Documentation of data concerning tolerability and efficacy of the intravenous treatment with vinflunine performed under daily routine conditions in Germany. The trial focusses on tolerability including the assessment of the usage of anti-emetic and anti-obstipative concomitant treatment as well as on the efficacy of the treatment.</brief_summary>
	<brief_title>JAVLORÂ® Online Non-Interventional Trial</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma, Transitional Cell</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<criteria>At least 18 years old Legally competent male and female patients Advanced or metastatic transitional cell carcinoma of the urothelium Failure of a prior Cisplatinumcontaining treatment Performance Status 0 or 1 Signed patient informed consent Missing signed patient informed consent Performance Status 2 or higher Life expectancy &lt; 2 months Brain metastases Creatinineclearance &lt; 20 ml/min ChildPughstadium C Prothrombin time &lt; 50% Bilirubin &gt; 5 x ULN Transaminases &gt; 6 x ULN GammaGlutamyltransferase &gt; 15 x ULN Pregnant or breastfeeding women Known/suspected hypersensitivity against vinflunine or other vincaalkaloids Recent (within the last 2 weeks) or current severe infections Baseline ANC &lt; 1,500/mm3 or platelets &lt; 100,000/mm3 Patients being institutionalised due to court/regulatory order</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>TCCU</keyword>
	<keyword>advanced TCCU</keyword>
	<keyword>metastatic TCCU</keyword>
	<keyword>transitional cell carcinoma of the urothelium</keyword>
	<keyword>advanced transitional cell carcinoma of the urothelium</keyword>
	<keyword>metastatic transitional cell carcinoma of the urothelium</keyword>
	<keyword>Cisplatinum failure</keyword>
	<keyword>Vinflunine</keyword>
	<keyword>Javlor</keyword>
	<keyword>daily routine</keyword>
	<keyword>concomitant antiemetic treatment</keyword>
	<keyword>concomitant antiobstipative treatment</keyword>
	<keyword>concomitant antiobstipative diet</keyword>
	<keyword>patient compliance</keyword>
	<keyword>quality of life</keyword>
	<keyword>non-interventional study</keyword>
	<keyword>Germany</keyword>
	<keyword>Advanced / metastatic TCCU after Cisplatinum-failure</keyword>
</DOC>